MediPharm Labs Corp. (LABS) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to the Metaform Labs conference call to discuss its first quarter 2025 results. Our speakers on today's call are David Piddick, President and Chief Executive Officer, and Greg Hunter, Chief Financial Officer. As a reminder, all participants are in listen-only mode and the conference is being recorded. After management's presentation, we will take questions from the analyst community on the telephone and then take written questions through the Q&A feature on the webcast. The information contained in this presentation should be considered together with the more detailed information, disclosure, financial data, and statements available on the company's website and on CEDARplus profile. As seen on slide two and three, I would like to note that this earnings call contains forward-looking information that is based on the company's current expectations, estimates, and beliefs as of today's date, and will also use terms that are non-IFRS financial measures. Please review the company's most recent disclosure materials for the risks associated with the use of forward-looking information and the use of non-IFRS financial measures in this presentation. Please note that all dollar amounts mentioned on today's call are in Canadian dollars, unless otherwise noted. And now I would like to turn the call over to Mr. David Pittek. Good morning, everyone, and thank you for joining us today. We will focus on the strategic progress and momentum in our business that has driven our improved results. Later in the call, I will discuss the evolving situation involving a dissident shareholder. Since becoming CEO in 2022, the MetaFarm team and I have worked tirelessly to implement a strategic plan that focused on growing and diversifying revenues, improving ...